Annual report pursuant to Section 13 and 15(d)

Schedule of Accounts Payable (Details)

v3.25.0.1
Schedule of Accounts Payable (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]      
Accounts payable interest rate 12.00% 13.00%  
Other accounts payable $ 453,000 $ 562,000  
Total accounts payable 3,853,000 4,328,000  
Cytovance Biologics Inc [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Accounts payable $ 1,183,000 $ 3,515,000 $ 2,264,000
Accounts payable interest rate 31.00% 81.00%  
University of Minnesota [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Accounts payable $ 712,000 $ 121,000  
Accounts payable interest rate 18.00% 3.00%  
Legal Services Firm [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Accounts payable $ 1,505,000 $ 130,000  
Accounts payable interest rate 39.00% 3.00%